Carmona joins MedWise campaign
This article was originally published in The Tan Sheet
Executive Summary
New print ads on OTC safety feature Surgeon General Richard Carmona, MD, "speaking" to consumers about OTC medicines, the National Council on Patient Information & Safety announces March 8. The campaign, initially launched last fall by NCPIE and FDA, presents Carmona's "prescription" for taking OTCs, including questions for health care providers on what OTCs are available for certain conditions and how often the drugs should be taken (1"The Tan Sheet" Sept. 15, 2003, p. 8). Full-, half-, and quarter-page ads will be sent to health journals and pharmacy organizations to be distributed to senior and community centers. In addition, national radio spots in English and Spanish will warn against taking more than one OTC at a time with the same active ingredient...
You may also be interested in...
“MedWise Prescription” Education Campaign Targets Rx-OTC Interactions
The latest "MedWise" consumer education campaign will focus on warning patients against the potential for overdosing when mixing OTC and prescription drugs with the same active ingredients
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.